AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

In general, strive to use antibiotics covering a spectrum no ... If oral therapy is possible: Nonsevere: metronidazole 500 mg three-times daily (t.i.d.) orally for 10 days; Severe: vancomycin ...

GBS antibiotic prophylaxis has been demonstrated ... 2008 Elsevier Science, Inc. Metronidazole (Flagyl) 500 mg orally twice a day for 7 days Metronidazole (Flagyl) 250 mg orally three times ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...